series-b
Stage
1
Investors
About
Locus Biosciences designs and develops targeted antimicrobials that circumvent known antibiotic resistance mechanisms while selectively sparing non-target bacteria.
Explore Locus Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.